Belpointe Asset Management LLC Astrazeneca PLC Transaction History

Belpointe Asset Management LLC

$1.49 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $43,131 - $48,902	683 Added 6.29%	11,547 $801,000
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $36,429 - $47,335	-672 Reduced 5.83%	10,864 $736,000
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $90,982 - $232,947	1,716 Added 17.47%	11,536 $632,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $117,571 - $141,141	-1,984 Reduced 16.81%	9,820 $648,000
Q1 2022 Apr 28, 2022	BUY	$55.72 - $67.12 $188,835 - $227,469	3,389 Added 40.27%	11,804 $783,000
Q4 2021 Feb 15, 2022	SELL	$54.02 - $63.83 $243,900 - $288,192	-4,515 Reduced 34.92%	8,415 $491,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $368,640 - $403,341	6,635 Added 105.4%	12,930 $776,000
Q2 2021 Aug 09, 2021	SELL	$48.42 - $60.18 $11,039 - $13,721	-228 Reduced 3.5%	6,295 $377,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $18,533 - $21,394	-393 Reduced 5.68%	6,523 $324,000
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $167,442 - $200,227	-3,451 Reduced 33.29%	6,916 $346,000
Q3 2020 Nov 13, 2020	SELL	$53.07 - $61.1 $3,980 - $4,582	-75 Reduced 1.58%	4,685 $209,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $301,543 - $347,170	5,682 Added 121.28%	10,367 $568,000
Q2 2020 Jul 20, 2020	BUY	$43.1 - $55.31 $3,232 - $4,148	75 Added 1.6%	4,760 $252,000
Q1 2020 Jul 20, 2020	SELL	$37.79 - $51.33 $2,834 - $3,849	-75 Reduced 1.58%	4,685 $209,000
Q4 2019 Feb 18, 2020	SELL	$42.46 - $50.46 $16,389 - $19,477	-386 Reduced 7.5%	4,760 $238,000
Q3 2019 Jan 16, 2020	SELL	$40.12 - $45.47 $27,442 - $31,101	-684 Reduced 11.73%	5,146 $229,000
Q2 2019 Nov 22, 2019	SELL	$37.28 - $41.68 $3,728 - $4,168	-100 Reduced 1.69%	5,830 $0
Q1 2019 Jun 11, 2019	SELL	$35.49 - $43.02 $4,755 - $5,764	-134 Reduced 2.21%	5,930 $240,000
Q4 2018 Mar 06, 2019	BUY	$36.86 - $41.49 $39,624 - $44,601	1,075 Added 21.55%	6,064 $230,000
Q3 2018 Nov 23, 2018	BUY	$34.76 - $39.72 $173,417 - $198,163	4,989 New	4,989 $197,000
Q2 2018 Aug 06, 2018	SELL	$34.55 - $37.05 $288,492 - $309,367	-8,350 Closed	0 $0
Q1 2018 Aug 06, 2018	SELL	$32.97 - $36.63 $94,195 - $104,651	-2,857 Reduced 25.49%	8,350 $292,000
Q4 2017 Feb 15, 2018	BUY	$32.09 - $34.78 $67,068 - $72,690	2,090 Added 22.92%	11,207 $389,000
Q3 2017 Nov 16, 2017	BUY	$28.96 - $34.0 $264,028 - $309,978	9,117	9,117 $309,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account